Connect with Us

About

Innovating Digital Healthcare into the Now

Our hope with this gift is that HMS and HBS continue to evolve their working relationship and produce the next generation of leaders who are at the center of transforming our healthcare system

Jim Tananbaum, MD ’89, MBA ’91

We are in the midst of an extraordinary era of innovation in medicine and healthcare delivery, fueled by the exponential growth of biomedical data, machine learning and artificial intelligence. Through the generous donation of Jim and Dana Tananbaum, the Tananbaum Healthcare Transformation Fund aims to fuel the innovation to impact pipeline, enabling the creation of health technologies and companies of the future. Jim recognizes that the future of what it means to be a physician will be radically different decades from now. He envisions a world where current scientific progress that is enabling the creation of new drugs and diagnostics will become the cornerstone of medical practice for the individual.

The Tananbaums’ gift will support the building of critical computational and data infrastructure that is needed to support the broad application of machine learning (ML) and artificial intelligence (AI) methodology to health care and its delivery. ML and AI algorithms need large amounts of data for training and to help identify potential problems with doctor-patient interactions, such as bias. It will be advantageous for researchers and clinicians at HMS to have access to large, well-curated data resources—and that is what this gift will enable. We will be able to purchase data and hire top computational scientists to support active research.

In addition, the gift will support activities that enable entrepreneurship, helping to create the technologies and companies of the future that will provide in-home and personalized care for everyone. Such activities will involve extensive collaboration between HMS and Harvard Business School (HBS). This fund will engage, enable, and build a community of innovative scientists, clinicians, and students across Harvard within the areas of health care policy, regulatory science, business, and entrepreneurship with the aim of improving healthcare and its delivery. Together, we are building a framework for the future of health care.

  • Knowledgebase

    Guidance in the form of key summaries to help navigate the innovation process including Regulations, Reimbursement, Cost Modeling, and Clinical Trials.

  • Expertise

    We offer entrepreneurial and technical expertise is to all Harvard community members, including hospital affiliates, who are interested in building a platform for digital health products.

  • Platforms

    Our expert team of computational and data scientists aim to build safe and secure platforms for innovators to cross-pollinate and ideate the future of health care.

  • Software

    We are developing tools that enables entry into the digital health innovation pipeline without the technical know-how.

  • Community

    We host programming, including our IM-Tech (Innovation in Medical Technology Entrepreneurship Cross-Harvard), to allow entrepreneurs, clinicians, and researchers to network and ideate together.

  • Data

    As we develop, we aim to procure data sets that are highly valuable to innovators from market insights to training, modeling, and testing of digital health products.

1 / 6

“As health care transforms to tech-enabled and distributed individualized care, it will need leadership that has been trained in medical science, but also appreciates how to deliver high-quality health care products to the individual and how to continuously improve the way care is delivered”

Jim Tananbaum, MD’89, MBA ’91

Table of Contents